BioGaia Logo

BioGaia

Develops and commercializes clinically proven probiotics for digestive health across all life stages.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0017769987 (+1 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioGaia is a biotechnology company specializing in the research, development, and commercialization of probiotic products. Since its founding in 1990, the company has focused on developing clinically proven probiotics to support digestive health and overall well-being for all life stages. Its product portfolio is based on patented strains of Lactobacillus, with key offerings like the BioGaia Protectis® line. This includes probiotic drops for infants, which are researched to help with common digestive issues such as colic, constipation, and diarrhea. BioGaia positions itself as a science-driven leader in its field, providing products that help maintain a healthy intestinal microflora.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 08:00
Quarterly Report
Swedish 1.6 MB
2025-10-22 08:00
Quarterly Report
English 1.5 MB
2025-08-22 17:30
Post-Annual General Meeting Information
Extra bolagsstämma i BioGaia
Swedish 149.3 KB
2025-08-22 17:30
Board/Management Information
Extraordinary General Meeting of BioGaia
English 71.0 KB
2025-07-25 09:31
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i BioGaia AB (publ)
Swedish 169.8 KB
2025-07-25 09:31
Pre-Annual General Meeting Information
Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)
English 199.0 KB
2025-07-18 08:01
Interim Report
Swedish 20.6 MB
2025-07-18 08:01
Interim Report
English 18.4 MB
2025-06-18 14:20
Major Shareholding Notification
Swedish 10.0 KB
2025-05-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Förändrat antal röster i BioGaia AB (publ)
Swedish 261.2 KB
2025-05-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Change in the number of votes in BioGaia AB (publ)
English 231.4 KB
2025-05-21 14:04
Declaration of Voting Results & Voting Rights Announcements
Swedish 10.0 KB
2025-05-20 13:01
Major Shareholding Notification
Swedish 10.7 KB
2025-05-14 16:43
Declaration of Voting Results & Voting Rights Announcements
Swedish 10.0 KB
2025-05-12 16:39
Major Shareholding Notification
Swedish 10.0 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioGaia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

Company Country Ticker View
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America ANNX

Talk to a Data Expert

Have a question? We'll get back to you promptly.